Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study

BACKGROUND: Acute osteomyelitis is typically caused by Gram-positive pathogens, commonly antibiotic-resistant Staphylococcus species. Standard antibiotic treatment is challenging due to required multiple daily doses, therapeutic drug monitoring, and parenteral administration for at least 4 weeks. Or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs Real World Outcomes
Autors principals: Van Hise, Nicholas W., Chundi, Vishnu, Didwania, Vishal, Anderson, Michael, McKinsey, David, Roig, Ingrid, Sharma, Akhilesh, Petrak, Russell M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334313/
https://ncbi.nlm.nih.gov/pubmed/32588385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-020-00195-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars